ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Kapruvia®:Vifor Fresenius Medical Care Renal Pharma Ltd.
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
V03AX04 - DifelikefalinATC-DDD Version 2016. Source: WHO
V - Various
 

This group comprises many different types of drugs, and assigning DDDs are difficult. Very few DDDs are assigned in this group.

V03 - All Other Therapeutic Products
 
V03A - All Other Therapeutic Products
 
V03AX - Other Therapeutic Products

This group comprises agents, which cannot be classified in the preceding groups.
Nalfurafine and difelikefalin indicated for pruritus in chronic kidney disease are classified here.

V03AX04 - Difelikefalin
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home